跳至主要内容
临床试验/CTRI/2012/12/003214
CTRI/2012/12/003214进行中(未招募)4 期

A RANDOMISED, OPEN-LABEL CLINICAL TRIAL TO ASSESS CERTAIN METABOLIC SIDE EFFECTS OF NOVEL ATYPICAL ANTIPSYCHOTICS - BLONANSERIN IN COMPARISON WITH AMISULPRIDE,IN PERSONS WITH PSYCHOSIS.

MYSORE MEDICAL COLLEGE AND RESEARCH INSTITUTE0 个研究点目标入组 56 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age between 18 - 60 years.
  • Both sexes.
  • Subjects with recent onset of psychotic symptoms and those with past history of psychotic symptoms having recurrence of psychotic symptoms currently.
  • Subjects who give informed consent.

排除标准

  • Subjects with suicidal tendencies.
  • Subjects having diabetes mellitus and abnormal lipid profile.
  • Acute infections or any serious concurrent illness.
  • Presence of organic brain syndrome (delirium, dementia).
  • Presence of alcohol and substance abuse/dependence, epilepsy, mental retardation, pregnancy and lactation.
  • Subjects who are on or who have received other antipsychotics in the last year.
  • Non complying subjects who are unable to give consent for the study

研究者

发起方
MYSORE MEDICAL COLLEGE AND RESEARCH INSTITUTE

相似试验